1 Reason Rocket Lab Stock Could Be a Monster Winner

Rocket Lab shares have shed nearly all their 2026 gains despite a record backlog and a deal that could fundamentally transform the company's revenue profile, and the gap between where the stock sits today and where our model puts it…

Published September 2, 2026, 11:30am ET · 3 min read

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

A smiling businessman in a dark suit looks down at a silver laptop, standing against a vibrant, digitally enhanced background. The background features a glowing financial graph with a grid and numbers on the Y-axis, abstract network lines, and a blurred cityscape. A white and red rocket with a fiery exhaust plume is seen launching upwards on the right side of the image, appearing to climb the financial chart, symbolizing rapid growth.
An entrepreneur monitors market performance as Rocket Lab's stock continues its upward trajectory, reflecting strong business fundamentals and future potential for investors. © ImageFlow / Shutterstock.com

Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) has become one of the most watched space stocks on the market, and our proprietary model sees room for a sizable move higher.

The one reason it could turn into a monster winner: a launch-plus-systems-plus-applications flywheel that few competitors can match, now backed by a $2.36 billion backlog and a pending transformative acquisition.

Metric Value
Current Price $63.92
24/7 Wall St. Price Target $123.10
Upside 92.59%
Recommendation BUY
Confidence Level 50%

Our 24/7 Wall St. price target for Rocket Lab is $123.10 over the next 12 months, implying meaningful upside. Confidence sits at medium, appropriate for a pre-profit growth story with a high-beta profile.

An infographic titled 'Rocket Lab (NASDAQ: RKLB) 12-Month Price Prediction' on a dark background with green and red accents. It displays a current price of $63.92 and a price target of $123.10, indicating a 'BUY' with +92.6% upside and a 'Medium (50%)' confidence level. A section 'HOW WE GOT THERE' shows a valuation breakdown with an analyst consensus of $112.94, supported by 78% bullish sentiment. 'OUR ADJUSTMENTS (247Factor)' illustrates a base price of $112.94 adjusted by a +1.09x multiplier to the final target of $123.10, listing factors like bullish analyst and retail sentiment, industrials sector momentum, and a volatility penalty. The 'BULL CASE' section, marked green, lists factors like 'Neutron On Track: Q4 2026 Pad Delivery', 'Iridium Acquisition: $870M+ Annual Recurring Revenue Added', and 'Defense Tailwinds', leading to a target of $156.54 (+144.9% Upside). The 'BEAR CASE' section, marked red, lists 'Financial Pressure', 'Equity Dilution: $1.53B ATM Proceeds in H1 2026', and 'Execution Risk', resulting in a target of $96.31 (+50.7% Upside). The 'BOTTOM LINE' reiterates 'BUY' -> '$123.10 (+92.6% Upside)' with a concluding statement about backlog conversion and defense demand.
24/7 Wall St.
RKLB price target

A Backlog-Driven Reset After a Volatile Summer

RKLB has been volatile. Shares hit $151 earlier in the trading year before pulling back to the low $60s, and are now down 8.37% year to date and 6.39% over the past week. Over five years, the stock is up 530.37%.

Q2 2026 was a record quarter. Revenue grew 62% year over year to $234.07 million, beating consensus by 1.35%. GAAP EPS of -$0.08 came in just below the -$0.0767 estimate, weighed down by $8.576 million in acquisition-related transaction costs.

Non-GAAP gross margin expanded to 41.5%, and management guided Q3 revenue to $250 million to $265 million. CEO Peter Beck noted “more than a billion dollars in new contracts across launch and space systems already entered into in Q3.”

RKLB analyst ratings

Why Bulls See a Breakout Ahead

The bull thesis: Rocket Lab is becoming a self-launching, tier-one space power. The Iridium acquisition adds a constellation of 66 satellites, 2.5 million subscribers, and roughly $870 million in annual recurring revenue. Neutron is tracking to Q4 2026 delivery to the pad, with more than 400 hot fires completed.

Defense tailwinds are enormous, with the FY2027 Golden Dome program requesting $17.9 billion and the U.S. Space Force budget climbing to $71.2 billion. If Neutron flies cleanly and Iridium closes, the bull case points to $156.54, or roughly 144.91% upside.

RKLB price scenario

Risks Worth Watching

The bear case is real. RKLB posted a Q2 net loss of $49.258 million, and fiscal 2025 free cash flow was -$321.806 million. Rocket Lab raised $1.53 billion in ATM equity in H1 2026, and Q3 basic shares are guided to 641 million.

Any Neutron slippage or Iridium regulatory hiccup could compress the multiple fast. The dilution funded a $2.129 billion cash war chest and a strategic acquisition that transforms the revenue mix. Our bear-case target lands at $96.31, still above today’s price.

How Rocket Lab Compares to Lockheed Martin and Iridium

Lockheed Martin (NYSE:LMT) is the defense-prime benchmark and a fellow Golden Dome contractor. LMT carries a record $230.42 billion backlog and guided 2026 EPS to $29.95 to $30.65, versus RKLB’s -$0.2682 full-year EPS estimate. LMT trades on cash flow today; RKLB trades on option value. That gap justifies a growth multiple on Rocket Lab.

Iridium Communications (NASDAQ:IRDM) is the recurring-revenue engine RKLB is acquiring. IRDM did $225.24 million in Q2 revenue with 2.63 million subscribers and a market cap near $5 billion. Once folded in, IRDM derisks Rocket Lab’s cash flow profile, making our $123.10 target reasonable rather than aggressive.

Rocket Lab Price Prediction 2026-2030

Year 24/7 Wall St. Price Target
2026 $74
2027 $123
2028 $204
2029 $256
2030 $323

These projections assume Rocket Lab executes on Neutron, closes Iridium, and continues winning defense contracts. Significant upside or downside could result from Neutron’s inaugural launch outcome.

Our 24/7 Wall St. price target is $123.10 with a buy rating and medium confidence. The tipping factor is the backlog conversion story combined with defense demand.

The setup favors investors who can stomach the volatility and a multi-year hold while Neutron scales. The setup weakens materially if Neutron slips into 2027 or Iridium’s approval drags. On balance, the risk-reward looks compelling.

Contact [email protected] for any questions or corrections.

Vandita Jadeja

Vandita Jadeja is a financial copywriter who loves to read and write about stocks. She believes in buying and holding for long term gains. Her knowledge of words and numbers helps her write clear stock analysis. She has contributed to several publications, including the Joy Wallet, Benzinga, The Motley Fool and InvestorPlace.

All articles →